PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

Communicating complex medical information has the potential to overwhelm patients and caregivers. The key is blending ...

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...

Merck & Co – known as MSD outside the US and Canada – has entered into an exclusive global licensing agreement worth over ...

What makes a story powerful? Storytelling is becoming more critical than ever. In medical publications, healthcare providers ...

The European Medicines Group (EMG) has appointed Sanofi’s Rippon Ubhi as its new chair. Ubhi, who will maintain her position ...

Our transforming healthcare symposium was held on Tuesday 5th November 2024. In this article, Prof Phil Richardson (Chief ...

New Environmental, Social and Governance (ESG) regulations coming into force across the EU in 2025 stand to shift how ...

This Movember, Innovative Trials are raising awareness about men’s health issues like prostate cancer, testicular cancer, and ...

The medical communications (med comms) industry is critical in bridging the gap between new medical innovations, healthcare ...

Merck KGaA and Abbisko Therapeutics have announced positive results from a late-stage study of pimicotinib in patients with ...